Published in Cancer Weekly, August 5th, 2003
The enzyme, present in most major types of cancer cells, gives cells the lethal ability to divide rampantly without dying. The laboratory experiments create an opportunity for researchers who are focusing on telomerase in a bid to develop a drug like none ever developed - one capable of killing 85% of cancers
The research, led by Peter T. Rowley, MD, of the University of Rochester Medical Center, was presented at the annual meeting of the American Association for Cancer Research in Washington, DC.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.